PHILADELPHIA, PA – March 10, 2014 -- Invisible Sentinel Inc., a life-sciences company that develops rapid diagnostics for the food and beverage industries, congratulates Paul Touhey, the company's Executive Chairman, on his receipt of Pennsylvania BIO's Hubert J.P. Schoemaker Leadership Award.
Touhey, formerly President and Chief Executive Officer of Fujirebio Diagnostics, Inc., will be honored at Pennsylvania BIO's Annual Dinner and Awards Celebration March 12 at the Pennsylvania Convention Center in Philadelphia. The leadership award recognizes an outstanding leader in the life-sciences community who exemplifies the spirit of innovation. Touhey is a previous winner of Pennsylvania BIO's CEO of the Year Award.
"We at Invisible Sentinel understand why Paul has earned enormous respect from everyone who has had the privilege to work with him," said Nicholas Siciliano, Chief Executive Officer at Invisible Sentinel. "He combines enthusiasm for innovation with the leadership skills required to turn bright ideas into marketed products. He positively influences the people around him, and they are better for it."
Touhey became Executive Chairman of Invisible Sentinel in 2013, following his appointment to the Board of Directors the previous year. During his leadership of Fujirebio Diagnostics, the company became the worldwide leader in cancer-diagnostics. Previously, he served at the Centocor Diagnostics unit of Centocor, Inc., and at Johnson & Johnson. He is also a member of the Board of Directors of the University City Science Center and Tela Bio, Inc.
The Leadership Award recognizes the late Hubert J.P. Schoemaker, Ph.D., a founder of Centocor, Inc. (now Jannsen Biotech, Inc.) and Neuronyx, Inc. (now Garnet Biotherapeutics), and a mentor to many in the life-sciences industry.
Pennsylvania BIO is the statewide trade association for the life sciences in Pennsylvania.
About Invisible Sentinel
Based in Philadelphia at the University City Science Center, Invisible Sentinel develops diagnostic technologies for a safer food supply. The Company focuses on developing rapid diagnostics that quickly provide accurate information about the presence of harmful pathogens. The first-in-class patented technology, produced under good manufacturing practices, provides the same data as the US Department of Agriculture reference methods but minimizes the time, reduces the cost, and lowers the overhead associated with conventional diagnostics. The food and beverage industry is the first market that the Company is targeting, but its platform technology has the potential to provide valuable tools for additional industries including healthcare, veterinary medicine, biodefense, and environmental testing, where rapid detection of target analytes from unrefined samples is critical. Uniquely designed for easy, practical use -- on-site and throughout the entire food distribution network -- Invisible Sentinel's proprietary diagnostic products promise to create a new standard for rigorous quality control.
SOURCE: Invisible Sentinel Inc.